Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulimorelin for Post-Operative GI Recovery (ULISES)
NCT01285570Phase 3Completed
- Sponsor
- Tranzyme Pharma
- Start
- Jan 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules, Cyclic Peptides
- Countries
- 7
01
Overview
A Phase 3 trial of ulimorelin in postoperative ileus (POI), sponsored by Tranzyme Pharma. Started Jan 2011; status: completed.
02
Drugs
ulimorelin
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT01285570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01285570.